STAT6 and neoplasm: Since NTRK1 is a target of EGR1, the central hub involved in NAB2-STAT6-dependent deregulation of gene expression [10,38], our results may suggest that an increased EGR1 transcriptional program could lead to a more aggressive tumor phenotype.